In this issue:
ECCO guidelines on extraintestinal manifestations in IBD
Biological treatment cycles in CD
MRE scores correlate with mucosal healing in paediatric CD
Mirikizumab as induction and maintenance therapy for UC
Delayed ustekinumab response has a similar prognosis to early response in UC
Effect of biologics on the risk of advanced-stage IBD-associated intestinal cancer
Remote monitoring tool for assessing infections in IBD
SARS-CoV-2 infection in patients with IBD
Self-evidence-based digital care programme improves HRQoL
Patients with CD and permanent ileostomy are universally excluded from clinical trials
Declining enrolment and other challenges in IBD clinical trials
COVID-19 resources
Conferences, workshops, and CPD
Please login below to download this issue (PDF)